Atalanta Therapeutics, a Boston biotechnology company making medicines for the brain from RNA molecules, has raised $97 million to bring its first two drug candidates into clinical testing.

Atalanta midfielder Andrea Rinaldi died, aged 19, on Monday three days after suffering a brain aneurysm. The teenager became ill on Friday while training at his home in Como, in the north of Italy ...